Please use this identifier to cite or link to this item: http://hdl.handle.net/2080/3907
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPraharaj, Prakash P.-
dc.contributor.authorBhutia, Sujit K.-
dc.date.accessioned2023-01-16T05:52:02Z-
dc.date.available2023-01-16T05:52:02Z-
dc.date.issued2022-12-
dc.identifier.citationInternational Conference on Recent Advances in Biological Sciences -2022 (RABS-2022), Vikram Deb Autonomous College, Jeypore, Odisha, India, 23-24 December 2022en_US
dc.identifier.urihttp://hdl.handle.net/2080/3907-
dc.descriptionCopyright belongs to proceeding publisheren_US
dc.description.abstractAutophagy affects tumorigenicity and malignancy by regulating cancer stem cell (CSCs) populations. In this study, we demonstrate that cisplatin treatment increases autophagosome formation and speeds up autophagosome-lysosome fusion, thus enriching the CSCs population. An intriguing discovery is that cisplatin treatment boosts autophagic flux by increasing lysosomal activity. In addition, both ATG5 and BECN1 are required for autophagy activation, which is critical for cancer stemness, self-renewal, and cisplatin cytotoxicity in CD44+ cells. Pharmacological inhibition of autophagy (chloroquine; 20 µM; 3 h) increases ROS production, which in turn enhances cisplatin-driven apoptosis in CD44+ CSCs. Further, we showed that cisplatin treatment activates NRF2 (nuclear factor, erythroid 2 like 2) signaling in autophagy-deficient CSCs, which in turn decreases the elevated ROS level and improves cancer stemness. Finally, silencing NRF2 with siNRF2 (a genetic approach) or ML-385 (a pharmacological inhibitor of NRF2) decreased cancer stemness in autophagy-deficient CD44+ cells. Inhibiting autophagy (using CQ) and NRF2 (using ML-385) simultaneously increased cisplatin-induced cytotoxicity and suppressed the expansion of oral CSCs, which may help treat CSC-associated drug resistance and tumor relapse in oral cancer.en_US
dc.subjectAutophagyen_US
dc.subjectapoptosisen_US
dc.subjectcancer stem cellen_US
dc.subjectNRF2en_US
dc.subjectoral canceren_US
dc.subjectmtROSen_US
dc.titleAutophagy and NRF2 antioxidant signaling are co-targeted to selectively sensitize cancer stem cells to apoptosisen_US
dc.typePresentationen_US
Appears in Collections:Conference Papers

Files in This Item:
File Description SizeFormat 
2022 _RABS_PPraharaj_Autophagy.pdf4.92 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.